SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041713
Filing Date
2019-11-07
Accepted
2019-11-07 16:04:57
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20190930.htm   iXBRL 10-Q 2998992
2 EX-31.1 flxn-ex311_11.htm EX-31.1 10142
3 EX-31.2 flxn-ex312_9.htm EX-31.2 10221
4 EX-32.1 flxn-ex321_7.htm EX-32.1 9132
  Complete submission text file 0001564590-19-041713.txt   10971915

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA flxn-20190930.xsd EX-101.SCH 59666
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20190930_cal.xml EX-101.CAL 65559
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20190930_def.xml EX-101.DEF 190313
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20190930_lab.xml EX-101.LAB 492573
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20190930_pre.xml EX-101.PRE 367511
42 EXTRACTED XBRL INSTANCE DOCUMENT flxn-10q_20190930_htm.xml XML 2436461
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 191200240
SIC: 2834 Pharmaceutical Preparations